Back to Search Start Over

SEOM-GEMCAD-TTD Clinical Guideline for the diagnosis and treatment of esophageal cancer (2021)

Authors :
Ana Fernández-Montes
Julia Alcaide
María Alsina
Ana Belén Custodio
Lourdes Fernández Franco
Javier Gallego Plazas
Carlos Gómez-Martín
Paula Richart
Fernando Rivera
Marta Martin-Richard
Institut Català de la Salut
[Fernández-Montes A] Medical Oncology Department, Complexo Hospitalario Universitario de Ourense, Ourense, Spain. [Alcaide J] Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain. [Alsina M] Medical Oncology Department, Hospital Universitario de Navarra (HUN), Pamplona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Custodio AB] Medical Oncology Department, Hospital Universitario la Paz, CIBERONC Madrid, Spain. [Franco LF] Medical Oncology Department, Hospital Virgen de la Salud, Toledo, Spain. [Gallego Plazas J] Medical Oncology Department, Hospital General Universitario de Elche, Elche, Alicante, Spain
Vall d'Hebron Barcelona Hospital Campus
Source :
Scientia, CLINICAL & TRANSLATIONAL ONCOLOGY, r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe, instname
Publication Year :
2022

Abstract

Diagnosis; Esophageal cancer; Treatment Diagnóstico; Cáncer de esófago; Tratamiento Diagnòstic; Càncer d'esòfag; Tractament Esophageal cancer is an aggressive tumor, and is the sixth-leading cause of death from cancer. Incidence is rising in Spain, particularly among men. Two main pathological different subtypes have been described: squamous cell carcinoma and adenocarcinoma. Growing evidence of their epidemiology and molecular differences explains their different response to novel treatments, and they are therefore likely to be treated as two separate entities in the near future. The best results are obtained with a multidisciplinary therapeutic strategy, and the introduction of immunotherapy is a promising new approach that will improve prognosis. In these guidelines, we review the evidence for the different methods of diagnosis and therapeutic strategies that form the basis of our standard of care.

Details

ISSN :
16993055 and 1699048X
Volume :
24
Issue :
4
Database :
OpenAIRE
Journal :
Clinicaltranslational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Accession number :
edsair.doi.dedup.....7573ec4bcf44240d793a5852f7f6ac42